Hi Dgoynich, That's a great idea! Still an awful lot still to...

Hi Dgoynich,

That's a great idea! Still an awful lot still to come. That was a bloody long list! I am always amused with how quickly sentiment can change with essentially no real new news. All that is coming now and still to come over the next 12 months has been well flagged in advance. It's great to see the company again start to get the attention it truly deserves.

It's also a much nicer experience reading the posts when everyone is a little happier. Some are still complaining about having high averages. I understand that not everyone will have had the funds to lower their average but fortune favours the brave. There has been plenty of time and opportunity to add to AHZ before today below .33 cents.

Fingers crossed that that opportunity is gone forever now, but who knows? At least any rise this time is genuinely backed by improving fundamentals (Excellent cost controls, capital management, rising sales, excellent improving margins, increasing geographies, indications and products.)

Genuine turnarounds that have been as hated and unloved as Admedus can have very powerful multi year re rates. The combination of improved revenues (soon profits) with a willingness by the market to pay more for those revenues can have a dramatic impact on share price performance.

Fingers crossed for Thursday but whatever happens we have a company that currently attributes zero value to Immunotherapies (let alone the significant opportunity in TAVR - IP to be lodged within the next 8 weeks and massive markets such as India and Mexico coming online this year.)

So good or bad results on Thursday we are in a sound position. If the HSV 2 results are not as good as we would like it will be no fault of the company, management or Professor Frazer (they have truly done their best) it will just be a natural part of the drug development process. However, I am quietly confident. I am also excited to see if we hear who our partner is for the RNA - Immuno Oncology collaboration. I wish everyone the very best of luck.

We all truly deserve this moment as does the company, today, tomorrow and into the future.

Exciting times ahead

"We have a point to prove"
CEO - Wayne Paterson - 16th of March 2017